tolvaptan has been researched along with Hypokalemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Butler, J; Campia, U; Chioncel, O; Gheorghiade, M; Khan, SS; Konstam, MA; Maggioni, AP; Nodari, S; Rossignol, P; Senni, M; Subacius, H; Swedberg, K; Vaduganathan, M; Zannad, F | 1 |
Berger, K; Der-Nigoghossian, C; Lesch, C | 1 |
Burnett, JC; Demets, D; Gheorghiade, M; Grinfeld, L; Konstam, MA; Maggioni, A; Orlandi, C; Swedberg, K; Udelson, JE; Zannad, F; Zimmer, C | 1 |
1 trial(s) available for tolvaptan and Hypokalemia
Article | Year |
---|---|
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Double-Blind Method; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypokalemia; Placebos; Quality of Life; Research Design; Stroke Volume; Survival Rate; Tolvaptan; Treatment Outcome; Urination; Ventricular Dysfunction, Left | 2005 |
2 other study(ies) available for tolvaptan and Hypokalemia
Article | Year |
---|---|
Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial).
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Clinical Trials as Topic; Creatinine; Female; Follow-Up Studies; Heart Failure; Humans; Hyperkalemia; Hypokalemia; Inpatients; Kaplan-Meier Estimate; Life Expectancy; Male; Middle Aged; Potassium; Research Design; Risk Factors; Stroke Volume; Tolvaptan; Treatment Outcome | 2015 |
Effectiveness and Tolerability of Conivaptan and Tolvaptan for the Treatment of Hyponatremia in Neurocritically Ill Patients.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cohort Studies; Critical Illness; Female; Humans; Hypokalemia; Hyponatremia; Injections, Intravenous; Male; Middle Aged; Nervous System Diseases; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome | 2017 |